Advertisement

Same vs Different Order for Second Readings of Mammograms in Rates of Breast Cancer Detection

Advertisement

Key Points

  • Researchers changed the case order for the two readers, expecting them to experience low vigilance when examining different women's mammograms.
  • In addition to finding no effect on cancer detection rate, in an exploratory post hoc analysis, they found that their overall performance improved with time on task.
  • While the readers kept up a constant rate of detecting cancer, the number of women they recalled for further tests to achieve this decreased over time.

A new study has found there is no decline over time in the accuracy of medical staff who analyze mammogram scans for indications of breast cancer. Researchers at the University of Warwick investigated whether detection rates dropped toward the end of each batch of mammogram readings. The study findings were published by Taylor-Phillips et al in JAMA.

Sian Taylor-Phillips, MSc, PhD, Assistant Professor at Warwick, and colleagues examined whether a phenomenon called “the vigilance decrement” would apply, whereby the accuracy of repetitive tasks decreases over time. To the research team's surprise, they found that the cancer detection rates throughout each batch of approximately 35 readings didn't change. They had expected accuracy to decline toward the end of each batch.

Dr. Taylor-Phillips said, “We found no reduction in performance or vigilance decrement at all. In fact, we found the opposite of what we were expecting—breast-screening readers seemed to get ‘into the zone,’ and their performance improved with time on task. They recalled fewer women for further tests as they got nearer the end of the batch, while cancer detection rates stayed constant.”

In the UK National Health Service Breast Screening Programme, two readers separately examine each woman's mammograms for signs of cancer. Women have mammograms taken of both breasts, and these are examined for signs of cancer by trained staff. Both readers scrutinize batches of around 35 women's mammograms. By current practice, both readers examine the x-rays in the same order as one another, so if they both experience a vigilance decrement, the vigilance will be low for both readers when examining the same women's mammograms.

Study Findings

To test the vigilance decrement theory, the researchers changed the case order for the two readers, expecting them to experience low vigilance when examining different women's mammograms. A real-world randomized controlled study in UK clinical practice was conducted incorporating 1.2 million women's x-rays in the trial.

In addition to finding no effect on cancer detection rate, in an exploratory post hoc analysis, they found that their overall performance improved with time on task.

While the readers kept up a constant rate of detecting cancer, the number of women they recalled for further tests to achieve this decreased over time. When readers first sat down and started the task, they recalled on average 6.4 women per thousand screened; this decreased to 4.6 per thousand screened after examining 40 mammograms.

Dr. Taylor-Phillips said, “Psychologists have been investigating a phenomenon of a drop in performance with time on a task called ‘the vigilance decrement’ since World War II. In those days radar operators searched for enemy aircraft and submarines, which appeared as little dots of light on a radar screen. People thought that the ability to spot the dots might go down after too much time spent on the task. Many psychology experiments have found a vigilance decrement, but most of this research has not been in a real-world setting, unlike our study.”

Dr. Taylor-Phillips and her team are going to expand their research in this area. They are currently analyzing how performance changes over longer reading sessions and whether examining mammograms at different times of day affects performance.

The content in this post has not been reviewed by the American Society of Clinical Oncology, Inc. (ASCO®) and does not necessarily reflect the ideas and opinions of ASCO®.


Advertisement

Advertisement




Advertisement